United States · FDA National Drug Code directory
Bumetanide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67184-0593_b392cf53-2b1f-46b5-86dc-c0df49f16730
- Product NDC
- 67184-0593
- Form
- INJECTION
- Composition / generic term
- Bumetanide
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240919
- Source listing expiry
- 20261231
Source-listed ingredients
- BUMETANIDE — .25 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (67184-0593-2) / 4 mL in 1 VIAL (67184-0593-1) · 67184-0593-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →